Vaxart Names W. Mark Watson as New Lead Independent Director

Written by Emily J. Thompson, Senior Investment Analyst

Source: Newsfilter

Updated: Sep 17 2025

0mins

Source: Newsfilter

Director Appointment: Vaxart, Inc. has appointed W. Mark Watson as Lead Independent Director, bringing over 50 years of experience in accounting and board positions in the biotech sector.
Stock Ownership Policy: The Board of Directors is adopting a stock ownership policy to align the interests of Directors with those of stockholders, emphasizing transparency and communication with investors.
Voting Reminder: Vaxart encourages stockholders of record as of July 29, 2025, to vote on the reverse stock split proposal by September 18, 2025, and allows those who previously voted against it to change their votes.
Special Meeting Announcement: A special meeting of stockholders will be held virtually on September 19, 2025, to discuss the proposals outlined in the Proxy Statement.

Discover Tomorrow's Bullish Stocks Today

Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.